Davis Jennifer L. — SEC insider filings
SEC reporting owner CIK 1916665. 27 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 27 filings on record, filed 2022-08-05 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 9 filings — 88,627 shares, $13,671,514 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: sale of 27,809 shares @ $147.95 ($4,114,342) in PROCTER & GAMBLE Co, filed 2022-08-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PROCTER & GAMBLE Co (PG) | CEO - Health Care | 23 | — | 9 legs · 88,627 sh · $13,671,514 | 48 |
| AbbVie Inc. (ABBV) | Director | 3 | — | — | 3 |
| ALIGN TECHNOLOGY INC (ALGN) | CEO-elect, Director | 1 | — | — | — |
Insider filings — Davis Jennifer L.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 3 | ALIGN TECHNOLOGY INC (ALGN) | Holdings only — no transactions reported | EDGAR |
| 2026-05-12 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 1,118 @ $0 | EDGAR |
| 2025-12-05 | 4 | PROCTER & GAMBLE Co (PG) | Option exercise (M): 60.43 @ $144.35 · Tax withholding (F): 60.43 @ $144.35 · Grant/award (A): 33.96 (derivative) @ $0 · Option exercise (M): 60.43 (derivative) @ $0 | EDGAR |
| 2025-10-06 | 4 | PROCTER & GAMBLE Co (PG) | Sale (S): 3,227 @ $152.23 | EDGAR |
| 2025-10-02 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 68,869 (derivative) @ $0 | EDGAR |
| 2025-08-21 | 4 | PROCTER & GAMBLE Co (PG) | Sale (S): 8,596 @ $157.27 | EDGAR |
| 2025-08-20 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 21,518 @ $0 · Grant/award (A): 24.94 (derivative) @ $0 | EDGAR |
| 2025-08-07 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 23.87 (derivative) @ $0 · Grant/award (A): 0.63 (derivative) @ $0 · Grant/award (A): 1,026 (derivative) @ $0 | EDGAR |
| 2025-05-13 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 1,203 @ $0 | EDGAR |
| 2025-04-30 | 4 | PROCTER & GAMBLE Co (PG) | Sale (S): 1,000 @ $161.38 · Grant/award (A): 22.16 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | PROCTER & GAMBLE Co (PG) | Option exercise (M): 46.27 @ $169.79 · Tax withholding (F): 46.27 @ $169.79 · Grant/award (A): 21.68 (derivative) @ $0 · Option exercise (M): 46.27 (derivative) @ $0 | EDGAR |
| 2024-10-03 | 4 | PROCTER & GAMBLE Co (PG) | Sale (S): 4,447 @ $171.65 · Grant/award (A): 56,554 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | PROCTER & GAMBLE Co (PG) | Sale (S): 6,223 @ $169.22 · Grant/award (A): 16.96 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 15,971 @ $0 | EDGAR |
| 2024-08-05 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 16.81 (derivative) @ $0 · Grant/award (A): 17.10 (derivative) @ $0 · Grant/award (A): 103.92 (derivative) @ $0 · Grant/award (A): 783 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 1,322 @ $0 | EDGAR |
| 2023-12-08 | 4 | PROCTER & GAMBLE Co (PG) | Option exercise (M): 47.58 @ $149.40 · Tax withholding (F): 47.58 @ $149.40 · Grant/award (A): 17.59 (derivative) @ $0 · Option exercise (M): 47.58 (derivative) @ $0 | EDGAR |
| 2023-10-04 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 52,251 (derivative) @ $0 | EDGAR |
| 2023-08-21 | 4 | PROCTER & GAMBLE Co (PG) | Sale (S): 5,761 @ $152.85 | EDGAR |
| 2023-08-18 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 12,843 @ $0 · Grant/award (A): 12.29 (derivative) @ $0 | EDGAR |
| 2023-08-04 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 12.18 (derivative) @ $0 · Grant/award (A): 108.69 (derivative) @ $0 · Grant/award (A): 791 (derivative) @ $0 | EDGAR |
| 2023-04-25 | 4 | PROCTER & GAMBLE Co (PG) | Option exercise (M): 23,943 @ $78.52 · Sale (S): 23,943 @ $155.27 · Grant/award (A): 13.19 (derivative) @ $0 · Option exercise (M): 23,943 (derivative) @ $0 | EDGAR |
| 2022-12-09 | 4 | PROCTER & GAMBLE Co (PG) | Option exercise (M): 37.47 @ $149.18 · Tax withholding (F): 37.47 @ $149.18 · Grant/award (A): 13.09 (derivative) @ $0 · Option exercise (M): 37.47 (derivative) @ $0 | EDGAR |
| 2022-10-04 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 6,746 @ $0 · Grant/award (A): 29,198 (derivative) @ $0 | EDGAR |
| 2022-08-24 | 4 | PROCTER & GAMBLE Co (PG) | Option exercise (M): 27,809 @ $91.07 · Sale (S): 27,809 @ $147.95 · Option exercise (M): 27,809 (derivative) @ $0 | EDGAR |
| 2022-08-18 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 19,021 @ $0 · Sale (S): 7,621 @ $149.33 · Grant/award (A): 8.62 (derivative) @ $0 | EDGAR |
| 2022-08-05 | 4 | PROCTER & GAMBLE Co (PG) | Grant/award (A): 8.23 (derivative) @ $0 · Grant/award (A): 115.78 (derivative) @ $0 · Grant/award (A): 623 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-06-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1916665 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs